CONMED Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, CONMED stock has a consensus rating of "Hold" and an average price target of $39. The average 1-year stock price forecast is 1.35% higher than the current stock price, while the lowest is $36 (-6.44%) and the highest is $40 (+3.95%).

Price Target: $39 (+1.35%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$36	$39	$39.5	$40
Change	-6.44%	+1.35%	+2.65%	+3.95%

Analyst Ratings

The average analyst rating for CONMED stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	0	0	0	0	0	0
Buy	1	0	0	0	0	0
Hold	5	6	6	6	5	6
Sell	0	0	0	0	1	1
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst BMO Capital No rating	BMO Capital	Hold Initiates $36	Hold	Initiates	$36	-6.44%	Jul 8, 2026
Travis Steed Bank of America Securities	Bank of America Securities	Sell Downgrades $40	Sell	Downgrades	$40	+3.95%	Jun 29, 2026
Robbie Marcus J.P. Morgan	J.P. Morgan	Hold Maintains $43 → $40	Hold	Maintains	$43 → $40	+3.95%	Apr 30, 2026
Matthew O'Brien Piper Sandler	Piper Sandler	Hold Reiterates $39	Hold	Reiterates	$39	+1.35%	Apr 30, 2026
Michael Matson Needham	Needham	Hold Maintains $33 → $36	Hold	Maintains	$33 → $36	-6.55%	Apr 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.36B

from 1.37B

-0.95%

from 1.37B

Revenue Next Year

1.43B

from 1.36B

5.28%

from 1.36B

EPS This Year

4.37

from 4.59

-4.90%

from 4.59

EPS Next Year

4.77

from 4.37

9.19%

from 4.37

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.01B	1.05B	1.24B	1.31B	1.37B	1.36B
Revenue Growth	17.18%	3.45%	19.06%	5.00%	5.18%	-0.95%
Gross Profit	568.04M	575.75M	676.25M	733.03M	740.58M	783.27M
Gross Margin	56.21%	55.07%	54.33%	56.08%	53.87%	57.53%
Operating Income	109.74M	87.17M	118.18M	159.28M	128.57M	202.98M
Net Income	62.54M	-80.58M	64.46M	132.42M	47.06M	120.49M
EPS	-	-	-	-	4.59	4.37
EPS Growth	-	-	-	-	10.07%	-4.90%
Forward PE	40.05	28.25	26.27	14.72	9.42	8.82
Dividend / Share	0.80	0.80	0.80	0.80	0.60	-
Dividend Growth	-	-	-	-	-25.00%	-100.00%
Free Cash Flow	95.51M	40.43M	175.72M	108.88M	169.27M	194.70M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	1.4B
Avg	1.4B
Low	1.4B

Revenue Growth

Revenue Growth	2026	2027	2028
High	-0.5%
Avg	-1.0%
Low	-1.4%

EPS Forecast

EPS	2026	2027	2028
High	4.40
Avg	4.37
Low	4.30

EPS Growth

EPS Growth	2026	2027	2028
High	-4.1%
Avg	-4.9%
Low	-6.3%